CAS 2460862-12-6 Utreglutide

Send Inquiry
CAS 2460862-12-6 Utreglutide
Details
CAS: 2460862-12-6
Sequence: His-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-{Lys(AEEA-Aib-γ-Glu-C18 diacid)}-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-Leu
We also provide specifications from crude to 99% purity, please contact us for details!

Related documents
COA/MS/HPLC Report
Peptide Dissolution and Storage Guide
Category
Pharmaceutical Peptides / Long-acting GLP-1 Receptor Agonist
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 2460862-12-6 utreglutide in China, also supports custom service. Welcome to wholesale bulk high quality cas 2460862-12-6 utreglutide from our factory. Contact us for more details.

 

Product name CAS:2460862-12-6:Utreglutide
Description Utreglutide is a long-acting GLP-1 receptor agonist. Aib substitution and side-chain C18 fatty acid modification improve metabolic stability, and albumin binding prolongs half-life. It is applied in mechanism research of type 2 diabetes, obesity and glucolipid metabolism.
Peptide purity (HPLC, %) 95%/98%/99%
Molecular formula C₁₉₁H₂₉₈N₄₆O₅₈
Molecular weight (Da) 4166.67

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Full Amino Acid Sequence Molecular Formula Exact Mass (Da) Average MW (Da) N-terminal Modification C-terminal Modification Sequence Length (aa)
Utreglutide Utreglutide; Long-acting GLP-1 agonist; CAS 2460862-12-6 GLP-1 receptor agonist,Long-acting metabolic peptide,Type 2 diabetes research,Obesity research,Albumin-binding long-acting,Glucolipid homeostasis regulation Histidine-α-aminoisobutyric acid-glutamic acid-glycine-threonine-phenylalanine-threonine-serine-aspartic acid-valine-serine-serine-tyrosine-leucine-glutamic acid-glycine-glutamine-alanine-alanine-lysine(side-chain conjugated AEEA-Aib-γ-Glu-C18 fatty diacid)-glutamic acid-phenylalanine-isoleucine-alanine-tryptophan-leucine-valine-arginine-glycine-arginine-glycine-leucine C₁₉₁H₂₉₈N₄₆O₅₈ 4164.21 4166.67 Free amine, with Aib unnatural amino acid substitution Free carboxyl 32 (core peptide backbone with side-chain long-acting modification)

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Conditions Short-term Storage Conditions Liquid Stability Solid Powder Stability
PEP-UTR001 white powder Solid powder: store at -20℃, protected from light, sealed and dry, aliquoted; avoid repeated freeze-thaw cycles Solid powder stable for 2 years at 2-8℃ sealed and dry; stock solutions recommended to be prepared in DMSO and stored at -80℃ in aliquots Stable for 72 h at 4℃; stable for 6 months at -80℃ in aliquots; stable for 1 month at -20℃ in aliquots. **Poor water solubility, DMSO required for solubilization**. Prone to aggregation and fibrillation upon prolonged storage; avoid repeated freeze-thaw and vigorous shaking Stable for 3 years at -20℃ under dry & dark conditions

 

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-UTR001 Long-acting GLP-1 receptor agonist with fatty acid modification for prolonged half-life, improves glucolipid metabolism and energy expenditure, applied in diabetes and obesity research Utreglutide is a long-acting glucagon-like peptide-1 receptor (GLP-1R) agonist. Its core backbone is engineered from the GLP-1 sequence, with Aib substitution at position 2 to significantly enhance DPP-IV resistance, and a C18 fatty diacid conjugated to the lysine at position 20 via an AEEA-Aib-γ-Glu linker, prolonging in vivo half-life via serum albumin binding and supporting once-weekly administration. It specifically activates GLP-1 receptors to mediate glucose-dependent insulin secretion, suppress glucagon release, delay gastric emptying and inhibit appetite. It also upregulates FGF21 and UCP-1 expression in adipose tissue to promote energy expenditure and lipolysis, improving glucolipid metabolism. Preclinical studies demonstrate potent glucose-lowering and weight loss effects, making it a core tool molecule for type 2 diabetes, obesity and metabolic syndrome mechanism research, as well as long-acting GLP-1 drug development. Type 2 diabetes research,Obesity mechanism research,Glucolipid metabolism research,Long-acting peptide drug development,Energy metabolism regulation research,GLP-1 pathway research Glucagon-Like Peptide-1 Receptor (GLP-1R); cAMP/PKA insulin secretion pathway; Appetite and gastric emptying regulatory pathway; Adipose tissue thermogenesis pathway

Hot Tags: cas 2460862-12-6 utreglutide, China cas 2460862-12-6 utreglutide manufacturers, suppliers, factory, 1415456-99-3, Cagrilintide, CAS 1415456 99 3, CAS 2381089 83 2, CAS 910463 68 2, Semaglutide

Send Inquiry